Jeuveau®
Temporary improvement of lateral canthal lines (crow's feet)
Key Facts
About Evolus
Evolus is a performance beauty company committed to delivering breakthrough products in the medical aesthetics market. Its primary mission is to challenge the established market leaders by offering high-quality, competitively priced products with a customer-centric commercial approach. The company's strategy involves expanding the use of its core neurotoxin, Jeuveau, into new indications and geographic markets, while also pursuing strategic partnerships and acquisitions to broaden its product portfolio. Evolus aims to capture significant market share by appealing to both core aesthetic providers and the growing segment of new-to-aesthetics consumers.
View full company profileAbout Evolus
Evolus is a performance beauty company committed to delivering breakthrough products in the medical aesthetics market. Its primary mission is to challenge the established market leaders by offering high-quality, competitively priced products with a customer-centric commercial approach. The company's strategy involves expanding the use of its core neurotoxin, Jeuveau, into new indications and geographic markets, while also pursuing strategic partnerships and acquisitions to broaden its product portfolio. Evolus aims to capture significant market share by appealing to both core aesthetic providers and the growing segment of new-to-aesthetics consumers.
View full company profileAbout Evolus
Evolus is a performance beauty company committed to delivering breakthrough products in the medical aesthetics market. Its primary mission is to challenge the established market leaders by offering high-quality, competitively priced products with a customer-centric commercial approach. The company's strategy involves expanding the use of its core neurotoxin, Jeuveau, into new indications and geographic markets, while also pursuing strategic partnerships and acquisitions to broaden its product portfolio. Evolus aims to capture significant market share by appealing to both core aesthetic providers and the growing segment of new-to-aesthetics consumers.
View full company profile